Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on May 13, 2025

Soroka Retains Top Ranking in Infection Control - Setting the Standard in Israel for Safe, Comprehensive Healthcare
BE'ER SHEVA, ISRAEL, May 13, 2025 /EINPresswire.com/ -- Soroka Medical Center has been ranked first among Israel’s major hospitals in infection prevention, according to the Israeli Ministry of Health’s 2024 National Infection Control Report. “This is not …

Spherion Greater Atlanta Expands Footprint: Local Staffing Powerhouse Steps Up to Serve All of Metro and Greater Atlanta
ATLANTA, GA, UNITED STATES, May 13, 2025 /EINPresswire.com/ -- Spherion Staffing and Recruiting Northeast Atlanta is proud to announce that its Northeast Atlanta office is now operating under a new name: Spherion Staffing and Recruiting Greater Atlanta. …

Media Advisory/OHC - Day of Action at Ontario Legislature to Stop Hospital Closures
TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- On Wednesday May 14, people from across Ontario will be heading into the Ontario Legislature for a “Day of Action” to ask the Ford government to stop closing their local hospitals and to provide the resources …

A4M's 2025 Spring Congress Expands The Clinical Impact Of Longevity Medicine
Boca Raton, Florida, May 13, 2025 (GLOBE NEWSWIRE) -- Nearly 3,000 healthcare professionals, a record-breaking turnout, converged on West Palm Beach this April for the American Academy of Anti-Aging Medicine's (A4M) 33rd Annual Spring Congress. This …

TigerConnect Fortalece Presencia Global con Nueva Oficina en Ciudad de México
CIUDAD DE MÉXICO, May 13, 2025 (GLOBE NEWSWIRE) -- TigerConnect, la principal plataforma unificada de comunicaciones para el cuidado de la salud anunció hoy la apertura de su nueva oficina regional en Ciudad de México. Ubicada en el corazón de Reforma, el …

Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development On-track to enable initiation of a clinical …

DANDY® CELERY LAUNCHES “SHUCK & SMILES” CONSUMER SWEEPSTAKES
Oviedo, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Dandy® Produce, a leading grower of fresh celery, radish and corn in the U.S., launches the “Shucks …

Guelph General Hospital receives $300,000 from Alectra to assist in establishing a new women’s health diagnostic imaging centre
MISSISSAUGA, Ontario, May 13, 2025 (GLOBE NEWSWIRE) -- Alectra Inc. is proud to announce a $300,000 contribution over five years to help establish a new community-based medical centre including a diagnostic imaging centre at Guelph General Hospital (GGH). …

AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
BERWYN, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- AscellaHealth has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2025. This prestigious award is presented by Financial Times and Statista Inc., the world-leading statistics …

ARC Fertility Wins 2025 MedTech Breakthrough Award for Best Reproductive Health Technology Solution
CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, has been named the winner of the 2025 MedTech …

Applied Pharmaceutical Innovation Appoints Dr. Launa Aspeslet as Chief Translational Officer to Accelerate Life Sciences Commercialization in Canada
EDMONTON, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Applied Pharmaceutical Innovation (API), one of Canada’s leading life sciences commercialization organizations, is proud to announce the appointment of Dr. Launa Aspeslet as its first Chief Translational …

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
Discussion in Virtual Investor CEO Connect focuses on Company’s planned follow-on market expansion study phase (“PoC 2”) of proof-of-concept trial; Access Here Additional indications potentially double the addressable market beyond pancreatic cancer pain …

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
MELVILLE, N.Y., May 13, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to …

BON Debuts Groundbreaking Broccoli-Derived Sleep Wellness Line, Reshaping the Sleep Health Market through Innovative Technology
XI’AN, China, May 13, 2025 (GLOBE NEWSWIRE) -- BON Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the natural health and personal care sectors, today announced the groundbreaking launch of …

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today agreed on terms for an exclusive collaboration agreement …

Serotonin Centers Announces Landmark Southeast Florida Area Development
MIAMI and FORT LAUDERDALE, Fla. and PALM BEACH, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging Centers (Serotonin Centers), the premier national anti-aging/longevity franchise, announced today a landmark multi-unit development agreement with …

Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification Platform
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Complement 1, a health tech startup transforming cancer care through personalized lifestyle medicine, today announced a $16 million oversubscribed seed funding round led by Owl Ventures and Blume Ventures. The …

Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 – – On track to initiate similarly-designed Phase 2 study in patients with COPD imminently – SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited ( …

Visory Health Expands Veteran Support Through New Partnership with Hope for the Warriors
ESTERO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Visory Health, a patient-first health tech prescription platform that is transforming the way Veterans, families, and caregivers access affordable healthcare through its prescription discount card, proudly …

Ensemble Announces Strategic Revenue Cycle Partnership with Jupiter Medical Center
Cincinnati, OH, May 13, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading revenue cycle managed services partner for healthcare organizations, announced today it has been selected by Jupiter Medical Center as their strategic revenue cycle management …